Welcome to LookChem.com Sign In|Join Free
  • or
2-CHLORO-N-(3-METHYLISOXAZOL-5-YL)ACETAMIDE is a chemical compound that features a chloro group, a methylisoxazol-5-yl group, and an acetamide group. It is widely recognized for its role as a building block in the synthesis of various compounds within the fields of medicinal and pharmaceutical research and development. The chloro group endows it with reactivity in organic synthesis reactions, while the acetamide group positions it as a potential pharmacophore for drug design. Moreover, the methylisoxazol-5-yl group imparts specific pharmacological properties, making it a promising candidate for the development of innovative drugs. In essence, 2-CHLORO-N-(3-METHYLISOXAZOL-5-YL)ACETAMIDE is a multifaceted chemical with broad applications in drug discovery and advancement.

69000-39-1

Post Buying Request

69000-39-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

69000-39-1 Usage

Uses

Used in Pharmaceutical Research and Development:
2-CHLORO-N-(3-METHYLISOXAZOL-5-YL)ACETAMIDE is utilized as a building block for the synthesis of diverse compounds, playing a crucial role in the creation of new pharmaceutical agents. Its structural components, including the chloro, methylisoxazol-5-yl, and acetamide groups, contribute to its versatility and potential in drug design.
Used in Organic Synthesis:
In the realm of organic synthesis, 2-CHLORO-N-(3-METHYLISOXAZOL-5-YL)ACETAMIDE is employed as a reactant due to the reactivity of its chloro group. This feature allows it to participate in various chemical reactions, facilitating the formation of a wide array of organic compounds.
Used in Drug Design:
The presence of the acetamide group in 2-CHLORO-N-(3-METHYLISOXAZOL-5-YL)ACETAMIDE renders it a potential pharmacophore, which is integral to the design of drugs with specific therapeutic effects.
Used in the Development of Novel Drugs:
The unique pharmacological properties conferred by the methylisoxazol-5-yl group make 2-CHLORO-N-(3-METHYLISOXAZOL-5-YL)ACETAMIDE a valuable component in the development of innovative drugs, targeting a range of therapeutic areas.

Check Digit Verification of cas no

The CAS Registry Mumber 69000-39-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,9,0,0 and 0 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 69000-39:
(7*6)+(6*9)+(5*0)+(4*0)+(3*0)+(2*3)+(1*9)=111
111 % 10 = 1
So 69000-39-1 is a valid CAS Registry Number.
InChI:InChI=1/C6H7ClN2O2/c1-4-2-6(11-9-4)8-5(10)3-7/h2H,3H2,1H3,(H,8,10)

69000-39-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-Chloro-N-(3-methyl-1,2-oxazol-5-yl)acetamide

1.2 Other means of identification

Product number -
Other names 2-chloro-N-(3-methylisoxazol-5-yl)acetamide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:69000-39-1 SDS

69000-39-1Downstream Products

69000-39-1Relevant academic research and scientific papers

Synthesis, DFT Study, and Antitumor Activity of Some New Heterocyclic Compounds Incorporating Isoxazole Moiety

Hamama, Wafaa S.,Ibrahim, Mona E.,Zoorob, Hanafi H.

, p. 1203 - 1212 (2017)

Thiazolidin-4-one derivative 3 was synthesized by the transformation of chloroacetamide derivative 2 with NH4SCN.The condensation of 3 with p-anisaldehyde afforded the corresponding arylidene derivative 4. Also, the alkylation of chloroacetamide derivative 2 with different heterocyclic compounds was investigated. Annulation of 5-amino-3-methylisoxazole (1) with α-halocarbonyl compounds 12 and 14 furnished pyrrolo[3,2-d]isoxazole and isoxazolo[5,4-b]azepin-6-one derivatives 13 and 15, respectively, while reaction of 1 with 1-chloro-4-(chloromethyl)benzene gave the monoalkylated product 17. The newly synthesized compounds were screened for their antitumor activity, and the geometry optimizations are in a good agreement with the experimentally observed data.

Design, synthesis, kinetic, molecular dynamics, and hypoglycemic effect characterization of new and potential selective benzimidazole derivatives as Protein Tyrosine Phosphatase 1B inhibitors

Campos-Almazán, Mara Ibeth,Flores-Ramos, Miguel,Hernández-Campos, Alicia,Castillo, Rafael,Sierra-Campos, Erick,Torgeson, Kristiane,Peti, Wolfgang,Valdez-Solana, Mónica,Oria-Hernández, Jesús,Méndez, Sara T.,Castillo-Villanueva, Adriana,Jiménez-de Jesús, Hugo,Avitia-Domínguez, Claudia,Téllez-Valencia, Alfredo

, (2021/09/28)

Protein-tyrosine phosphatase 1B (PTP1B) is a negative regulator of insulin signaling pathway and has been validated as a therapeutic target for type 2 diabetes. A wide variety of scaffolds have been included in the structure of PTP1B inhibitors, one of them is the benzimidazole nucleus. Here, we report the design and synthesis of a new series of di- and tri- substituted benzimidazole derivatives including their kinetic and structural characterization as PTP1B inhibitors and hypoglycemic activity. Results show that compounds 43, 44, 45, and 46 are complete mixed type inhibitors with a Ki of 12.6 μM for the most potent (46). SAR type analysis indicates that a chloro substituent at position 6(5), a β-naphthyloxy at position 5(6), and a p-benzoic acid attached to the linker 2-thioacetamido at position 2 of the benzimidazole nucleus, was the best combination for PTP1B inhibition and hypoglycemic activity. In addition, molecular dynamics studies suggest that these compounds could be potential selective inhibitors from other PTPs such as its closest homologous TCPTP, SHP-1, SHP-2 and CDC25B. Therefore, the compounds reported here are good hits that provide structural, kinetic, and biological information that can be used to develop novel and selective PTP1B inhibitors based on benzimidazole scaffold.

Isoxazole phosphates and phosphonates

-

, (2008/06/13)

Insecticidally active compounds are disclosed, defined by the general formula STR1 in which R is hydrogen or methyl; R1 is hydrogen or methyl; R2 is a member selected from the group consisting of methyl, methoxy, ethyl, and ethoxy; R3 is alkoxy having 1 to 6 carbon atoms; and X is oxygen or sulfur.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 69000-39-1